Leysen J E, Gommeren W, Janssen P F, Sanz G, Gillardin J M, Schotte A, Janssen P A
Janssen Research Foundation, Beerse, Belgique.
Allerg Immunol (Paris). 1991 Feb;23(2):51-7.
Four non-sedating antihistamines (astemizole, cetirizine, loratadine and terfenadine) were investigated for in vitro and ex vivo binding to histamine-H1 receptors in guinea-pig cerebellum and lung. In vitro, all the drugs dissociated slowly from H1 receptors (half-times greater than or equal to 100 min), Ki,app-values decreased with longer incubation times for potent lipophylic agents (astemizole and terfenadine) Ki,app-values were lower with more dilute tissue suspensions. In optimized assay conditions astemizole showed a Ki,app-value of 0.2 microM. Terfenadine, cetirizine and loratadine bound with 30-, 80- and 100-times lower affinity to H1 receptors. The occupancy of lung and cerebellar H1 receptors was investigated after oral administration of various dosages of the drugs and at several times after drug administration, using ex vivo binding techniques. Astemizole was a very potent compound showing complete differentiation between lung and cerebellar receptor occupation (with 0.63 mg/kg: 70% of lung H1 receptors were occupied, with less than 10% of cerebellar H1 receptor occupancy). A 7-times higher dose of terfenadine was required to induce the same effect. Astemizole produced a rapid and complete occupancy of lung receptors, which was maintained up to 72 h after administration. In contrast, terfenadine produced a peak effect at 1 h and was completely eliminated from lung receptors in 24 h. Loratadine and cetirizine only poorly differentiated between lung and cerebellar receptor occupancy (at 2.5 mg/kg: 70 and 60% of lung receptor occupancy, 50 and 70% of cerebellar receptor occupancy).(ABSTRACT TRUNCATED AT 250 WORDS)
研究了四种非镇静性抗组胺药(阿司咪唑、西替利嗪、氯雷他定和特非那定)在豚鼠小脑和肺中与组胺H1受体的体外和离体结合情况。在体外,所有药物从H1受体上解离缓慢(半衰期大于或等于100分钟),对于强效亲脂性药物(阿司咪唑和特非那定),表观解离常数(Ki,app)值随孵育时间延长而降低,在更稀的组织悬液中Ki,app值更低。在优化的测定条件下,阿司咪唑的Ki,app值为0.2微摩尔。特非那定、西替利嗪和氯雷他定与H1受体的亲和力分别低30倍、80倍和100倍。采用离体结合技术,在口服不同剂量药物后及给药后的不同时间,研究了肺和小脑H1受体的占有率。阿司咪唑是一种非常强效的化合物,在肺和小脑受体占有率方面表现出完全差异(0.63毫克/千克时:70%的肺H1受体被占据,小脑H1受体占有率不到10%)。需要7倍剂量的特非那定才能产生相同效果。阿司咪唑能迅速完全占据肺受体,给药后长达72小时仍能维持。相比之下,特非那定在1小时达到峰值效应,并在24小时内从肺受体中完全消除。氯雷他定和西替利嗪在肺和小脑受体占有率之间的差异很小(2.5毫克/千克时:肺受体占有率分别为70%和60%,小脑受体占有率分别为50%和70%)。(摘要截断于250字)